while the efficacy of daunorubicin ( dnr ) in first induction of patients with acute nonlymphoblastic leukemia ( anll ) has been well documented , little data are available concerning the activity of dnr in patients with relapsed and refractory anll previously treated with anthracycline .
C0011015
dnr
C0023467
anll